Core Biomarkers for Peptide Research
Bloodwork monitoring is essential when conducting peptide research protocols. Key markers provide objective data on how compounds affect physiological systems. Research-grade tracking should include comprehensive metabolic panels, hormone assessments, and organ function indicators.
Primary Monitoring Categories
Metabolic Markers: Glucose, HbA1c, insulin levels, and lipid panels track metabolic changes. These are particularly important when researching metabolic peptides like semaglutide or AOD-9604.
Growth Hormone Pathway: IGF-1, IGFBP-3, and growth hormone levels monitor GH-releasing peptide effects. Essential for CJC-1295, GHRP-2, and similar compounds.
Safety Markers: Complete blood count (CBC), comprehensive metabolic panel (CMP), and liver function tests (ALT, AST) ensure protocol safety. These should be monitored regardless of peptide type.
Timing and Frequency
Baseline measurements should be taken before starting any research protocol. Follow-up testing typically occurs at 4-6 week intervals, though some markers may require more frequent monitoring based on peptide half-life and research objectives.
Documentation Best Practices: Maintain detailed logs correlating bloodwork results with dosing schedules, administration timing, and any observed effects. This creates valuable research data for protocol optimization.
This information is for research purposes only and does not constitute medical advice. Consult qualified healthcare professionals before conducting any research involving human subjects.